The Potassium Supplementation Study
Launched by UNIVERSITY OF DELAWARE · May 30, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
**Summary of the Potassium Supplementation Study**
The Potassium Supplementation Study is looking to find out if taking potassium supplements can help protect healthy adults from the negative effects of eating a lot of salt. Salt, or sodium, can be harmful to our blood vessels and affect how our body controls blood pressure and heart function. This study aims to see if adding potassium to the diet can improve these conditions in people who are otherwise healthy.
To participate, you need to be between 18 and 45 years old and have a healthy weight (a Body Mass Index, or BMI, of less than 30). You must also have a normal blood pressure of less than 130/80 mmHg. Unfortunately, if you have certain health issues like high blood pressure, heart disease, diabetes, or kidney problems, you won't be able to join. If you take part in this study, you can expect to receive potassium supplements and help researchers learn more about heart health. It's a great opportunity to contribute to important health research!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • men and women
- • 18-45 years of age
- • all races/ethnicities
- • BMI \< 30 kg/m2
- • BP \< 130/80 mmHg
- Exclusion Criteria:
- • presence of hypertension
- • known heart disease
- • diabetes
- • kidney disease
- • cancer
- • inflammatory conditions
- • blood clotting disorders
- • pregnancy
- • adrenal gland disorder
- • history of stomach or intestinal bleeding
- • history of kidney stones
- • serum potassium outside of the normal range
About University Of Delaware
The University of Delaware, a renowned research institution, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, engineering, and behavioral health, to conduct rigorous and ethical research. The university's commitment to scientific excellence and community engagement ensures that its clinical trials not only contribute to groundbreaking discoveries but also prioritize participant safety and well-being. Through its state-of-the-art facilities and a team of experienced researchers, the University of Delaware is positioned to make significant contributions to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newark, Delaware, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported